Valerie Ceva

Title: Valerie Ceva: Innovator in Pharmaceutical Compositions

Introduction

Valerie Ceva is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative delivery systems for medications.

Latest Patents

Valerie Ceva holds a patent for "Vaginal delivery systems containing selective estrogen receptor modulator (SERM) and uses thereof." This patent describes pharmaceutical compositions that include one or more selective estrogen receptor modulator(s) (SERM(s), such as Lasofoxifene) combined with four or more pharmaceutically acceptable excipients. The compositions are designed to form nanodroplets in vaginal fluid, enabling effective delivery of the SERM(s) to the vagina of a female subject. These compositions may be beneficial in treating or preventing conditions such as vulvovaginal atrophy, dyspareunia, sexual dysfunction, osteoporosis, or breast cancer in women.

Career Highlights

Valerie Ceva is associated with Azure Biotech, Inc., where she continues to advance her research and development efforts. Her work focuses on creating innovative solutions that address critical health issues faced by women.

Collaborations

Valerie collaborates with esteemed colleagues, including Steven R Goldstein and Susan L Levinson, to further enhance the impact of her research in the pharmaceutical industry.

Conclusion

Valerie Ceva's contributions to pharmaceutical compositions and her innovative approach to women's health issues underscore her importance as an inventor in the field. Her work continues to pave the way for advancements in medical treatments.